Blue Trust Inc. Has $60,000 Stake in Globe Life Inc. (NYSE:GL)

Blue Trust Inc. lowered its stake in shares of Globe Life Inc. (NYSE:GL) by 46.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 542 shares of the company’s stock after selling 464 shares during the quarter. Blue Trust Inc.’s holdings in Globe Life were worth $60,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in GL. Versant Capital Management Inc boosted its holdings in shares of Globe Life by 388.0% in the 4th quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock valued at $27,000 after purchasing an additional 194 shares in the last quarter. Albion Financial Group UT bought a new stake in shares of Globe Life during the 4th quarter worth $28,000. True Wealth Design LLC acquired a new stake in Globe Life in the third quarter valued at about $59,000. Private Trust Co. NA grew its position in Globe Life by 67.5% in the third quarter. Private Trust Co. NA now owns 670 shares of the company’s stock valued at $71,000 after acquiring an additional 270 shares during the last quarter. Finally, Intact Investment Management Inc. bought a new position in Globe Life in the third quarter valued at about $73,000. Institutional investors own 81.61% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Evercore ISI raised shares of Globe Life from an “in-line” rating to an “outperform” rating and boosted their target price for the stock from $132.00 to $143.00 in a research note on Wednesday, January 8th. Jefferies Financial Group boosted their price objective on Globe Life from $107.00 to $114.00 and gave the stock a “hold” rating in a research report on Tuesday, December 10th. Wells Fargo & Company increased their target price on Globe Life from $126.00 to $141.00 and gave the company an “overweight” rating in a research report on Wednesday, February 19th. BMO Capital Markets began coverage on Globe Life in a report on Thursday, January 23rd. They set a “market perform” rating and a $114.00 price target on the stock. Finally, Keefe, Bruyette & Woods upped their price objective on Globe Life from $137.00 to $145.00 and gave the company an “outperform” rating in a research note on Wednesday, February 12th. Five analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Globe Life presently has a consensus rating of “Moderate Buy” and a consensus price target of $135.50.

Insider Transactions at Globe Life

In other news, CEO Frank M. Svoboda sold 14,340 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $108.80, for a total transaction of $1,560,192.00. Following the completion of the sale, the chief executive officer now owns 16,396 shares in the company, valued at $1,783,884.80. The trade was a 46.66 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Mark A. Blinn sold 3,000 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of $113.23, for a total value of $339,690.00. Following the completion of the transaction, the director now owns 5,122 shares in the company, valued at approximately $579,964.06. This represents a 36.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 75,678 shares of company stock valued at $8,799,822 in the last quarter. 1.51% of the stock is currently owned by company insiders.

Globe Life Price Performance

Globe Life stock opened at $122.66 on Tuesday. The stock’s 50 day moving average is $116.85 and its 200 day moving average is $109.57. Globe Life Inc. has a one year low of $38.95 and a one year high of $129.18. The firm has a market cap of $10.30 billion, a P/E ratio of 10.26 and a beta of 0.81. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, topping analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. As a group, research analysts expect that Globe Life Inc. will post 13.87 EPS for the current year.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.